Current Challenges in Cardiovascular Molecular Diagnostics
The field of cardiovascular genetics has tremendously benefited from the recent application of massive parallel sequencing technology also referred to as next generation sequencing (NGS). However, along with the discovery of additional genes associated with human cardiac diseases, the analysis of la...
Saved in:
Superior document: | Frontiers Research Topics |
---|---|
: | |
Year of Publication: | 2017 |
Language: | English |
Series: | Frontiers Research Topics
|
Physical Description: | 1 electronic resource (128 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993543534604498 |
---|---|
ctrlnum |
(CKB)4100000002484674 (oapen)https://directory.doabooks.org/handle/20.500.12854/44409 (EXLCZ)994100000002484674 |
collection |
bib_alma |
record_format |
marc |
spelling |
Carlo Napolitano auth Current Challenges in Cardiovascular Molecular Diagnostics Frontiers Media SA 2017 1 electronic resource (128 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Frontiers Research Topics The field of cardiovascular genetics has tremendously benefited from the recent application of massive parallel sequencing technology also referred to as next generation sequencing (NGS). However, along with the discovery of additional genes associated with human cardiac diseases, the analysis of large dataset of genetic information uncovered a much more complex and variegated landscape, which often departs from the comfort zone of the monogenic Mendelian diseases image that clinical molecular geneticists have been well acquainted with for many decades. It is now clear that, in addition to highly penetrant genetic variants, which in isolation are able to recapitulate the full clinical presentation when expressed in animal models, we are now aware that a small but significant fraction of subjects presenting with cardiac muscle diseases such as cardiomyopathies or primary arrhythmias such as long QT syndrome (LQTS), may harbor at least two deleterious variants in the same gene (compound heterozygous) or in different gene (double heterozygous). Although the clinical presentation in subjects with more than one deleterious variant appears to be more severe and with an earlier disease onset, it somehow changes the viewpoint of clinical molecular geneticists whose aim is to identify all possible genetic contributors to a human condition. In this light, the employment in clinical diagnostics of the NGS technology, allowing the simultaneous interrogation of a DNA target spanning from large panel of genes up to the entire genome, will definitely aid at uncovering all such contributors, which will have to be tested functionally to confirm their role in human cardiac conditions. The uncovering of all clinically relevant deleterious changes associated with a cardiovascular disease would probably increase our understanding of the clinical variability commonly occurring among affected family relatives, and potentially provide with unexpected therapeutic targets for the treatment of symptoms related to the presence of “accessory” deleterious genetic variants other than the key molecular culprit. The objective of this Research Topic is to explore the current challenges presenting to the cardiovascular genetics providers, such as clinical geneticists, genetic counselors, clinical molecular geneticists and molecular pathologists involved in the diagnosis, counseling, testing and interpretation of genetic tests results for the comprehensive management of patients affected by cardiovascular genetic disorders. English genetic variants Cardiovascular Diseases Genetic Testing channelopathy variant interpretation NGS Sudden cardiac death cardiomyopathy Cardiovascular genetics 2-88945-281-6 Jeffrey A. Towbin auth Guia Guffanti auth Luisa Mestroni auth Valeria Novelli auth Matteo Vatta auth |
language |
English |
format |
eBook |
author |
Carlo Napolitano |
spellingShingle |
Carlo Napolitano Current Challenges in Cardiovascular Molecular Diagnostics Frontiers Research Topics |
author_facet |
Carlo Napolitano Jeffrey A. Towbin Guia Guffanti Luisa Mestroni Valeria Novelli Matteo Vatta |
author_variant |
c n cn |
author2 |
Jeffrey A. Towbin Guia Guffanti Luisa Mestroni Valeria Novelli Matteo Vatta |
author2_variant |
j a t jat g g gg l m lm v n vn m v mv |
author_sort |
Carlo Napolitano |
title |
Current Challenges in Cardiovascular Molecular Diagnostics |
title_full |
Current Challenges in Cardiovascular Molecular Diagnostics |
title_fullStr |
Current Challenges in Cardiovascular Molecular Diagnostics |
title_full_unstemmed |
Current Challenges in Cardiovascular Molecular Diagnostics |
title_auth |
Current Challenges in Cardiovascular Molecular Diagnostics |
title_new |
Current Challenges in Cardiovascular Molecular Diagnostics |
title_sort |
current challenges in cardiovascular molecular diagnostics |
series |
Frontiers Research Topics |
series2 |
Frontiers Research Topics |
publisher |
Frontiers Media SA |
publishDate |
2017 |
physical |
1 electronic resource (128 p.) |
isbn |
2-88945-281-6 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT carlonapolitano currentchallengesincardiovascularmoleculardiagnostics AT jeffreyatowbin currentchallengesincardiovascularmoleculardiagnostics AT guiaguffanti currentchallengesincardiovascularmoleculardiagnostics AT luisamestroni currentchallengesincardiovascularmoleculardiagnostics AT valerianovelli currentchallengesincardiovascularmoleculardiagnostics AT matteovatta currentchallengesincardiovascularmoleculardiagnostics |
status_str |
n |
ids_txt_mv |
(CKB)4100000002484674 (oapen)https://directory.doabooks.org/handle/20.500.12854/44409 (EXLCZ)994100000002484674 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Frontiers Research Topics |
is_hierarchy_title |
Current Challenges in Cardiovascular Molecular Diagnostics |
container_title |
Frontiers Research Topics |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField |
_version_ |
1796652263984332801 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03830nam-a2200433z--4500</leader><controlfield tag="001">993543534604498</controlfield><controlfield tag="005">20231214133313.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2017 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000002484674</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/44409</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000002484674</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Carlo Napolitano</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Current Challenges in Cardiovascular Molecular Diagnostics</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (128 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The field of cardiovascular genetics has tremendously benefited from the recent application of massive parallel sequencing technology also referred to as next generation sequencing (NGS). However, along with the discovery of additional genes associated with human cardiac diseases, the analysis of large dataset of genetic information uncovered a much more complex and variegated landscape, which often departs from the comfort zone of the monogenic Mendelian diseases image that clinical molecular geneticists have been well acquainted with for many decades. It is now clear that, in addition to highly penetrant genetic variants, which in isolation are able to recapitulate the full clinical presentation when expressed in animal models, we are now aware that a small but significant fraction of subjects presenting with cardiac muscle diseases such as cardiomyopathies or primary arrhythmias such as long QT syndrome (LQTS), may harbor at least two deleterious variants in the same gene (compound heterozygous) or in different gene (double heterozygous). Although the clinical presentation in subjects with more than one deleterious variant appears to be more severe and with an earlier disease onset, it somehow changes the viewpoint of clinical molecular geneticists whose aim is to identify all possible genetic contributors to a human condition. In this light, the employment in clinical diagnostics of the NGS technology, allowing the simultaneous interrogation of a DNA target spanning from large panel of genes up to the entire genome, will definitely aid at uncovering all such contributors, which will have to be tested functionally to confirm their role in human cardiac conditions. The uncovering of all clinically relevant deleterious changes associated with a cardiovascular disease would probably increase our understanding of the clinical variability commonly occurring among affected family relatives, and potentially provide with unexpected therapeutic targets for the treatment of symptoms related to the presence of “accessory” deleterious genetic variants other than the key molecular culprit. The objective of this Research Topic is to explore the current challenges presenting to the cardiovascular genetics providers, such as clinical geneticists, genetic counselors, clinical molecular geneticists and molecular pathologists involved in the diagnosis, counseling, testing and interpretation of genetic tests results for the comprehensive management of patients affected by cardiovascular genetic disorders.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genetic variants</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Cardiovascular Diseases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Genetic Testing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">channelopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">variant interpretation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NGS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Sudden cardiac death</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiomyopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Cardiovascular genetics</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88945-281-6</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jeffrey A. Towbin</subfield><subfield code="4">auth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guia Guffanti</subfield><subfield code="4">auth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Luisa Mestroni</subfield><subfield code="4">auth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Valeria Novelli</subfield><subfield code="4">auth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Matteo Vatta</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:49:50 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2018-03-10 17:16:05 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337392970004498&Force_direct=true</subfield><subfield code="Z">5337392970004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337392970004498</subfield></datafield></record></collection> |